UT Southwestern Medical Center is partnering with Pfizer Inc. to develop RNA-enhanced delivery technologies for genetic medicine therapies through the Dallas-based medical center’s Program in Genetic Drug Engineering.
Catherine Spong, M.D., Chair and Professor of Obstetrics and Gynecology at UT Southwestern Medical Center, has been elected to the National Academy of Medicine (NAM) in recognition of her contributions to the field of maternal-fetal medicine, her leadership in women’s health research, and her dedication to advancing health care for mothers and babies.
UT Southwestern Medical Center has been recognized for its decades of commitment to developing female leaders in medicine and science and its far-reaching impact in supporting and advancing women’s careers.
For the third year in a row, UT Southwestern Medical Center is ranked among the nation’s best large employers on America’s Best Employers 2023 list compiled by Forbes and Statista, and is among this year’s top employers for new graduates, women, and employee diversity.
Japanese biochemist and molecular biologist Noboru Mizushima, M.D., Ph.D., has been named the inaugural recipient of the Beth Levine, M.D. Prize in Autophagy Research from UT Southwestern Medical Center. Dr. Mizushima is an internationally recognized scientist who has made significant strides in unraveling the complex processes of mammalian autophagy, a fundamental cellular mechanism responsible for maintaining cellular health and functionality.
UT Southwestern Medical Center is expanding its footprint to better serve the northwest Dallas region, offering primary care visits ranging from management of chronic health issues to women’s health exams at UT Southwestern Medical Center at Coppell.
UT Southwestern Medical Center has established the Beth Levine, M.D. Prize in Autophagy Research, an annual award and lecture for exceptional scientists who have made significant contributions to the field of autophagy.